CK Life Sciences International (Holdings), Inc. (0775.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
CK Life Sciences International (Holdings), Inc.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
1920
First IPO Date
January 04, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Ying Choi Yu | CEO & Executive Deputy Chairman | 12.04M | 1956 |
| Lee Yuen | Vice President, Chief Executive Officer & Executive Director | 15.03M | 1966 |
| Tzar Kuoi Li | Executive Chairman | 125,000 | 1964 |
| Tak Chuen | Senior Vice President, Chief Investment Officer & Executive Director | 1.1M | 1952 |
| Hing Lam Kam | President & Executive Director | 3.33M | 1946 |
| Kean Meng Toh | Vice President, Chief Scientific Officer & Executive Director | 6.78M | 1967 |
| Wai Che Tong Barnes | Chief Corporate Affairs Officer | 0 | 1960 |
| Yau Lin Wong | General Manager of Human Resources & Administration | 0 | 1967 |
| Pak To Wu | Chief Operating Officer of Global Operations | 0 | 1962 |
| Emily Tan | Chief Operating Officer | 0 | N/A |
| Sze Mun | Vice President of Corporate Development | 0 | 1972 |
| Ching Sze Chiu | General Counsel | 0 | 1977 |
| Wun Lam Wong | Chief Financial Officer | 0 | 1965 |
AD
Description
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related and Health. The company was founded on August 10, 2001 and is headquartered in Hong Kong.
AD